Form 4: Progyny Executive Sells Shares to Cover Tax Obligations

Progyny's Executive Vice President and General Counsel, Allison Swartz, sold 1,352 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Allison Swartz, Executive Vice President and General Counsel at Progyny, Inc., sold 1,352 shares of common stock on November 29, 2024.
• The sale was executed at a price of $15.48 per share.
• This transaction was to cover withholding taxes due upon the vesting of restricted stock units.
• Following the transaction, Ms. Swartz directly owns 64,027 shares of Progyny common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is not indicative of any positive or negative sentiment towards the company's performance or future prospects. The transaction is expected and does not raise any concerns.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Similar transactions are common across publicly traded companies, particularly in the technology and healthcare sectors where stock-based compensation is a significant part of executive pay.
• Companies like Teladoc Health (TDOC) and Livongo (now part of Teladoc) have seen similar filings from their executives related to stock sales for tax purposes.
• These transactions are generally viewed as a normal part of executive compensation and do not typically indicate a change in the executive's outlook on the company's future.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Progyny, stock sale, insider trading, Form 4, executive compensation, restricted stock units, tax obligations